Aller au contenu principal
Retour à l'annuaire
FB
RhumatologueMédecins généralistes et spécialistes👤 Libéral intégral

M. Docteur François BERTAGNA

📍 Paris (75)Libéral💶 Secteur 2RPPS 10000246016

Diplômes

🎓 DES & spécialité ordinale

  • Rhumatologie (SM)

📚 CES (Certificat d'Études Spéciales)

  • CES Rhumatologie

🎓 Diplômes

  • DE Docteur en médecine

Source : Annuaire Santé ANS (FHIR Practitioner.qualification) · Mises à jour quotidiennes.

Lieu de consultation

  • CABINET DU DR FRANCOIS BERTAGNA

    113 AVENUE VICTOR HUGO, 75116 Paris

    Libéral

Tarifs & secteur de conventionnement

🟡 Secteur 2 — Honoraires libresSource CNAM (Annuaire santé Ameli)
💳 Carte VitaleLibéral intégral

Prendre rendez-vous & contact

Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).

Top publications · les plus citées

  • 1
    State of the art of (18)F-FDG PET/CT application in inflammation and infection: a guide for image acquisition and interpretation

    Clinical and translational imaging · 2021

    📚 128 citations🎯 RCR 12.63Top 2% NIH🔓 Open Access📄 PDF gratuit ↗
  • 2
    Efficacy of the combination of nilutamide plus orchidectomy in patients with metastatic prostatic cancer. A meta-analysis of seven randomized double-blind trials (1056 patients)

    British journal of urology · 1994

    📚 77 citations🎯 RCR 2.55Top 20% NIH
    Lire l'abstract Crossref ↓

    Objective To review the efficacy of the combination of the anti‐androgen nilutamide (Anandron®) plus orchidectomy in patients with stage D prostate cancer who had received no previous treatment. Patients and methods The results of seven randomized double‐blind trials were analysed. In these studies patients were followed up until progression of disease or withdrawal for other reasons. Bone pain, urinary symptoms, performance status, levels of prostatic acid phosphatase (PAP) and alkaline phosphatase (AP) were evaluated before treatment and after 1, 3, 6, 12 and 18 months of treatment. Bone scans and X‐rays were taken every 6 months. The best objective response, the time of progression and the time of death were recorded. The changes from baseline in symptoms and levels of tumour markers at month six and the percentages of objective regressions in the two treatment groups were compared using the Cochran‐Mantel‐Haenszel test stratified by study. Peto's method was used for the analysis of time to progression and of survival. Results Of the 1191 patients enrolled in all the original trials, 1056 were eligible. In the group of patients treated with nilutamide 50% had complete or partial regression of disease compared with 33% of those who were given a placebo (P<0.001); bone pain and levels of PAP and AP were improved or returned to normal significantly more frequently (P< 0.01); the odds of disease progression were significantly reduced (odds ratio 0.84, P=0.05); the odds of death from cancer and from other causes were reduced but the difference was not statistically significant. Conclusions The combination of nilutamide and orchidectomy has a beneficial effect on pain of metastatic origin, levels of tumour markers, the objective response of disease and the time to disease progression. This treatment combination might also improve survival.

Publications scientifiques (7) — classées par pathologie

Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).

Transversal4

Essai clinique1

Goutte1

Revue / méta-analyse1

Sjögren1

Partager cette fiche

in LinkedIn🟢 WhatsApp✉ Email

Données ANS publiques (Licence Ouverte 2.0) · Enrichissements MonRhumato 100 % opt-in · Toute personne référencée peut demander la suppression ou la rectification.